Dark

Check out our Dark Pool Levels

CNBX
CNBX PHARMACEUTICAL INC
stock OTC

EOD

Aug 3, 2026

0.000100USD0.000%(0.000000)1,010,166

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Nov 4, 2021

08:33AM EDT CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase PR Newswire

Oct 26, 2021

09:16AM EDT Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago PR Newswire

Oct 25, 2021

09:00AM EDT Toll Brothers , CanAm Enterprises Form JV To Develop 293-Unit, 1,086 Bed Student Housing Community In Miami, Florida RTTNews

08:55AM EDT Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors PR Newswire

Oct 21, 2021

08:33AM EDT EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX PR Newswire

Oct 20, 2021

08:35AM EDT CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las PR Newswire

Oct 19, 2021

09:42AM EDT CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: PR Newswire

Oct 18, 2021

12:56PM EDT Cannabics Pharmaceuticals Announces Two New Provisional Patents: Compositions and Methods For Treating Cancer Benzinga

09:06AM EDT Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and PR Newswire

Oct 14, 2021

09:15AM EDT CEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to PR Newswire

Oct 7, 2021

05:10PM EDT Bullish Sentiment For Marijuana Stocks: Tilray, GrowGeneration & Canopy Growth Among Top Cannabis Movers For October 7, 2021 Benzinga

Sep 30, 2021

09:25AM EDT Cannabics Announces New Corporate Logo, New Website and New Company Presentation PR Newswire

Sep 22, 2021

09:15AM EDT Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David PR Newswire

Sep 21, 2021

09:20AM EDT Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in PR Newswire

Sep 15, 2021

10:47PM EDT Cannabis Movers & Shakers: Eden Empire, Cannabics Pharmaceuticals, Nabis Benzinga

Sep 13, 2021

08:25AM EDT Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of PR Newswire

Aug 23, 2021

08:59AM EDT Hemato-Oncology Expert, Dr. Sigal Tavor (MD) Joins Cannabics Pharmaceuticals' PR Newswire

Aug 4, 2021

08:02AM EDT World-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of PR Newswire

Jul 20, 2021

07:36AM EDT Cannabics Pharmaceuticals Appoints a Second Independent Board Member PR Newswire

Jul 10, 2021

02:02PM EDT Cannabis Movers & Shakers: Plus Products, Arcview Capital, Greenspoon Marder, KetamineOne, Open Book Extracts, Cannabics Pharmaceuticals, Sundial , Flora Growth Benzinga

Jul 7, 2021

08:51AM EDT Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member PR Newswire

Jun 28, 2021

08:44AM EDT Cannabics Says Its Drug Candidate Exhibits 30% Tumor Volume Reduction In Mice RTTNews

08:43AM EDT Cannabics Pharmaceuticals' Drug Candidate Exhibits 30% Tumor Volume Reduction PR Newswire

Jun 17, 2021

08:15AM EDT Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate PR Newswire

Jun 3, 2021

07:59AM EDT Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program PR Newswire

May 25, 2021

08:45AM EDT The European Patent Office Grants Cannabics Pharmaceuticals Patent for PR Newswire

May 11, 2021

12:38PM EDT The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More Benzinga

08:51AM EDT Cannabics Pharma Files PCT Patent Application For Proprietary Cancer Treatment Formulations RTTNews

08:45AM EDT Cannabics Pharmaceuticals Files a PCT Patent Application for Proprietary Cancer PR Newswire

May 7, 2021

05:36PM EDT The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More Benzinga

May 6, 2021

05:18PM EDT Cannabis Stock Gainers And Losers From May 6, 2021 Benzinga

09:25AM EDT Cannabics Pharmaceuticals Receives Patent "Notice of Allowance" From The PR Newswire

Apr 26, 2021

09:20AM EDT Cannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma PR Newswire

Apr 22, 2021

06:44PM EDT Cannabis Stock Gainers And Losers From April 22, 2021 Benzinga

Apr 21, 2021

03:34PM EDT Cannabis Stock Gainers And Losers From February 23, 2021 Benzinga

Apr 20, 2021

09:29AM EDT Cannabics Pharmaceuticals Launches New Research Program Using Psylocibin And Psilocin RTTNews

09:25AM EDT Cannabics Pharmaceuticals Launches Psilocybin and Psilocin Research Program PR Newswire

Mar 31, 2021

09:29AM EDT Cannabics Pharmaceuticals to Initiate in-vivo Dose Response Study on PR Newswire

Mar 17, 2021

09:29AM EDT Cannabics Says Drug Candidate RCC-33 Prolongs Survival Rate In Mice Inoculated With Human Colorectal Cancer Cells RTTNews

09:25AM EDT Cannabics Pharmaceuticals' Drug Candidate RCC-33 Prolongs Survival Rate in Mice PR Newswire

Mar 2, 2021

09:57AM EST Lexaria Bioscience Corp. is Changing the Future of Drug Delivery Benzinga

Feb 23, 2021

05:44PM EST Cannabis Stock Gainers And Losers From February 23, 2021 Benzinga

Feb 17, 2021

09:25AM EST Cannabics Pharmaceuticals' in-vivo Tumor Inhibitory Effect Study Concludes with PR Newswire

Feb 16, 2021

09:18AM EST Volume in Mice Treated with Company's Proprietary Drug Candidate for Colorectal Cancer PR Newswire

Feb 3, 2021

09:50AM EST Cannabics's Interim Study Results Show 27% Lower Tumor Volume In Mice Treated With Drug Candidate For Colorectal Cancer RTTNews

09:20AM EST Volume in Mice Treated with Company's Proprietary Drug Candidate for Colorectal Cancer PR Newswire

Dec 22, 2020

04:44PM EST Cannabis Stock Gainers And Losers From December 22, 2020 Benzinga

Dec 21, 2020

09:27AM EST Cannabics Pharmaceuticals Initiates In-Vivo Animal Studies for FDA Pre-IND PR Newswire

Dec 3, 2020

05:47PM EST Cannabis Stock Gainers And Losers From December 3, 2020 Benzinga

Nov 16, 2020

09:25AM EST Cannabics Pharmaceuticals Founds Digestix Bioscience Inc., a Subsidiary for PR Newswire

Nov 9, 2020

09:25AM EST Cannabics Concludes a Pre-Clinical Study on Human Biopsies in Preparation for PR Newswire

Oct 27, 2020

09:03AM EDT notice for its System and Method for High Throughput Screening of Cancer Cells patent application PR Newswire

Oct 21, 2020

09:09AM EDT Cannabics Prepares To Submit FDA With Pre-IND Meeting Request For Proprietary Colon Cancer Drug Candidate RTTNews

09:02AM EDT Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS(tm) RCC-33 PR Newswire

Aug 20, 2020

09:07AM EDT Cannabics To Establish Division For Antitumor Drug Candidate RCC-33 For Treatment Of Colorectal Cancer RTTNews

09:03AM EDT Cannabics Pharmaceuticals to Establish a Division for its Antitumor Drug PR Newswire

Aug 5, 2020

09:02AM EDT Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor (MD), PR Newswire

Jul 14, 2020

09:21AM EDT Cannabics Pharmaceuticals Initiates Penetration for Its Cannabinoid Diagnostic PR Newswire

Share